Ras-Related Associated with Diabetes (RRAD) (Middle Region) Peptide
-
- Target See all RRAD products
- RRAD (Ras-Related Associated with Diabetes (RRAD))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RRAD antibody (Catalog #: ARP56567_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RRAD (Ras-Related Associated with Diabetes (RRAD))
- Synonyms
- ZGC:63471 Peptide, RRAD Peptide, RAD Peptide, RAD1 Peptide, REM3 Peptide, Rad Peptide, RRAD, Ras related glycolysis inhibitor and calcium channel regulator Peptide, Ras-related associated with diabetes Peptide, RRAD Peptide, Rrad Peptide
- Background
-
RRAD may play an important role in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. RRAD regulates voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. RRAD inhibits cardiac hy
Alias Symbols: RAD, RAD1, REM3
Protein Interaction Partner: CALM1,CAMK2G,CSNK2A1,NME1,PRKACA,PRKCA,PRKCB,TPM2,YWHAZ,CAMK2G,NME1,TPM2,Tpm2,YWHAZ
Protein Size: 308 - Molecular Weight
- 33 kDa
- Gene ID
- 6236
- NCBI Accession
- NM_004165, NP_004156
- UniProt
- P55042
-